OMX Nordic 40
2.328,93
PKT
+17,74
PKT
+0,77
%
Werbung
Analysen zu OMX Nordic 40-Werten
Datum | Rating | Analyst | |
---|---|---|---|
01.04.25 | Nokia Overweight | JP Morgan Chase & Co. | |
01.04.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
01.04.25 | Volvo (B) Underperform | Bernstein Research | |
31.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | AstraZeneca Hold | Deutsche Bank AG | |
28.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
28.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
28.03.25 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
28.03.25 | Novo Nordisk Buy | UBS AG | |
28.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
28.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
27.03.25 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
27.03.25 | Volvo (B) Buy | Jefferies & Company Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
27.03.25 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
27.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
27.03.25 | A.P. Moeller - Maersk A-S (B) Sell | Deutsche Bank AG | |
27.03.25 | Volvo (B) Overweight | JP Morgan Chase & Co. | |
26.03.25 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
26.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
25.03.25 | ABB (Asea Brown Boveri) Hold | Jefferies & Company Inc. | |
25.03.25 | Volvo (B) Underweight | Barclays Capital | |
24.03.25 | Hennes Mauritz (H M, H&M) Sector Perform | RBC Capital Markets | |
24.03.25 | Novo Nordisk Buy | Deutsche Bank AG | |
24.03.25 | Hennes Mauritz (H M, H&M) Hold | Deutsche Bank AG | |
24.03.25 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
24.03.25 | Nokia Sell | Goldman Sachs Group Inc. | |
21.03.25 | Novo Nordisk Buy | UBS AG | |
18.03.25 | Volvo (B) Buy | Deutsche Bank AG | |
17.03.25 | Novo Nordisk Buy | UBS AG | |
17.03.25 | AstraZeneca Outperform | Bernstein Research | |
17.03.25 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
17.03.25 | AstraZeneca Buy | UBS AG | |
17.03.25 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
14.03.25 | Novo Nordisk Buy | UBS AG | |
13.03.25 | Volvo (B) Sector Perform | RBC Capital Markets |